BioNexus Gene Lab (BGLC) EBT Margin (2018 - 2026)
BioNexus Gene Lab recorded quarterly EBT Margin of 2379.72% in Q1 2026, down 1011.08% quarter-over-quarter from 214.18% in Q4 2025, and down 235055.0% year-over-year from N/an in Q1 2025.
BioNexus Gene Lab's EBT Margin history runs 9 years deep, the most recent figure standing at 2379.72% for Q1 2026.
- In Q1 2026, EBT Margin fell 235055.0% year-over-year to 2379.72%; the TTM figure through Mar 2026 stood at 54.7% (down 3166.0% YoY), while the FY2025 annual figure was 40.2%, down 2343.0% from the prior year.
- EBT Margin came in at 2379.72% for Q1 2026 at BioNexus Gene Lab, down from 214.18% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 12.9% in Q2 2024 to a low of 2379.72% in Q1 2026.
- A 5-year average of 167.61% and a median of 10.72% in 2023 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin jumped 4809 bps in 2024 and plunged 235055 bps in 2026, its largest moves.
- BioNexus Gene Lab's EBT Margin stood at 4.49% in 2022, then soared by 349 bps to 11.16% in 2023, then sank by 250 bps to 16.72% in 2024, then plunged by 1181 bps to 214.18% in 2025, then plunged by 1011 bps to 2379.72% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 2379.72%, 214.18%, and 27.87% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | 27.68% |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | 39.02% |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | 12.00% |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | 15.74% |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | 27.85% |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | 13.16% |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | 1.90% |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | 28.46% |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | 10.77% |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | -2,379.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,379.72% |
| Dec 31, 2025 | -214.18% |
| Sep 30, 2025 | -27.87% |
| Jun 30, 2025 | -27.26% |
| Mar 31, 2025 | -29.17% |
| Dec 31, 2024 | -16.72% |
| Sep 30, 2024 | -51.09% |
| Jun 30, 2024 | 12.90% |
| Mar 31, 2024 | -3.51% |
| Dec 31, 2023 | 11.16% |
| Sep 30, 2023 | -99.18% |
| Jun 30, 2023 | -10.72% |
| Mar 31, 2023 | -2.23% |
| Dec 31, 2022 | -4.49% |
| Sep 30, 2022 | -2.61% |
| Jun 30, 2022 | -5.64% |
| Mar 31, 2022 | 1.04% |
| Dec 31, 2021 | 6.07% |
| Sep 30, 2021 | 10.36% |
| Jun 30, 2021 | 4.42% |
| Mar 31, 2021 | 9.82% |
| Dec 31, 2020 | -0.18% |
| Sep 30, 2020 | 7.60% |
| Jun 30, 2020 | -3.20% |
| Mar 31, 2020 | 34.87% |
| Dec 31, 2019 | -181.24% |
| Sep 30, 2019 | -207.41% |
| Jun 30, 2019 | -319.79% |
| Mar 31, 2019 | -214.34% |
| Dec 31, 2018 | -673.39% |
| Sep 30, 2018 | -60.18% |